Search

everythinglearnresearchcommunity

for

Search:↓

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

Timely diagnosis of SLE is crucial due to symptom overlap with fibromyalgia.

Chitosan, a natural substance, can be used to create tiny particles that effectively deliver various types of drugs, but more work is needed to improve stability and control of drug release.

Common dermatology drugs were considered but are controversial for COVID-19 treatment.

γδ T cells are essential for wound healing after poxvirus infection.

Sertraline, an antidepressant, may rarely cause hair loss.

Long COVID is a big health problem needing more research and better treatments.

Lichen planus pigmentosus may indicate undetected hepatitis C infection.

Bioassays help find useful compounds in nature for making medicines, supplements, and cosmetics.

Most lab tests for patients with Telogen effluvium, a type of hair loss, show no or mild abnormalities; only a few specific tests are useful.

ICAM-1 helps regulate hair growth cycles and skin remodeling.

Metformin may help treat neuroendocrine tumors.

Rituximab may be an effective treatment for Cronkhite-Canada syndrome with kidney disease.

Early diagnosis and hormone therapy can significantly improve outcomes for post-partum pituitary insufficiency in resource-limited settings.

Higher CD70 and CD27 gene expression in alopecia areata lesions predicts disease severity and activity.

SOD1 and KL are promising targets for new hair loss treatments.

JAM-A helps hair regrowth in alopecia areata by protecting VCAN in skin cells.

A mix of methotrexate, corticosteroids, and topical minoxidil effectively treated severe total body hair loss, but caused stretch marks and needs long-term monitoring.

7-Phloroeckol from brown algae may help hair grow.

Therapy lowers IgM levels in dogs with severe dermatitis but not in mild cases.

A woman lost over 80% of her hair due to a condition called telogen effluvium after having COVID-19.

Obesity may contribute to female hair loss by increasing male hormone levels that affect hair follicles.

Excluding alopecia and mucous membrane components from the CLASI-A score reduces its effectiveness in capturing important disease activity.

Careful management of blood thinners is crucial for lupus patients with APS.

A woman with skin and joint issues progressed from one type of lupus to another, highlighting the need to recognize complex conditions.

The drug BAY 1158061 is safe, well-tolerated, and shows potential for treating diseases related to prolactin.

Stress in hair follicle cells increases certain immune-related proteins, which might contribute to hair loss conditions.

Male hormones affect COVID-19 severity and certain drugs targeting these hormones could help reduce the risk.

Thymus transplantation successfully restored immune function in infants with FOXN1 deficiency.

The drug enzalutamide may reduce the ability of the virus causing COVID-19 to enter lung cells.